TRS Publications

At the bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.

Luker GD, Yang J, Richmond A, Scala S, Festuccia C, Schottelius M, Wester HJ, Zimmermann J

J Leukoc Biol. 2020 Oct 26

A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.

Osl T, Schmidt A, Schwaiger M, Schottelius M, Wester HJ

Theranostics. 2020;10(18):8264-8280

[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center

P. Werner, C. Neumann, M. Eiber, H. J. Wester & M. Schottelius

EJNMMI Research. 2020 May; Volume 10, Article number: 45

From Theranostics to Immunotheranostics: the Concept

Niklaus Schaefer, John O. Prior & Margret Schottelius

54, pages 81–85(2020)

"Luke! Luke! Don't! It's a trap!"-spotlight on bias in animal experiments in nuclear oncology.

Nonnekens J, Schottelius M

Eur J Nucl Med Mol Imaging. 2020 May;47(5):1024-1026

Dernière mise à jour le 05/05/2020 à 11:26